Literature DB >> 9474830

Why do we continue to take unnecessary smears?

C B Woodman1, J Richardson, M Spence.   

Abstract

A questionnaire survey of all general practices and family planning doctors in Manchester Health Authority was undertaken to determine why many more smears are taken in primary care than are scheduled by the screening programme. An 82% response rate was obtained. The indications for additional smear tests most frequently cited by responders were postcoital (88%), postmenopausal (84%), or intermenstrual bleeding (55%); genital warts (87%); and multiple sexual partners (52%). Forty-six per cent think that a woman should have a repeat test within one year of her first ever test. We discuss why these are not valid indications for additional smear tests.

Entities:  

Mesh:

Year:  1997        PMID: 9474830      PMCID: PMC1410113     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  5 in total

1.  Cervical smears--an opportunity for disinvestment?

Authors:  M T Spence; C Woodman; S Collins; B Donnelly; M Desai
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

2.  Selective screening: theory and practice based on high-risk groups of cervical cancer.

Authors:  M Hakama; E Pukkala; P Saastamoinen
Journal:  J Epidemiol Community Health       Date:  1979-12       Impact factor: 3.710

3.  Meta-analysis of Pap test accuracy.

Authors:  M T Fahey; L Irwig; P Macaskill
Journal:  Am J Epidemiol       Date:  1995-04-01       Impact factor: 4.897

4.  Optimising the age, number of tests, and test interval for cervical screening in Canada.

Authors:  Y Shun-Zhang; A B Miller; G J Sherman
Journal:  J Epidemiol Community Health       Date:  1982-03       Impact factor: 3.710

5.  Human papillomavirus testing in primary cervical screening.

Authors:  J Cuzick; A Szarewski; G Terry; L Ho; A Hanby; P Maddox; M Anderson; G Kocjan; S T Steele; J Guillebaud
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

  5 in total
  2 in total

1.  Genital warts and cervical screening.

Authors:  T Greenhalgh
Journal:  Br J Gen Pract       Date:  1998-01       Impact factor: 5.386

2.  Cluster-randomised trial of risk communication to enhance informed uptake of cervical screening.

Authors:  Rachel M Holloway; Clare Wilkinson; Tim J Peters; Ian Russell; David Cohen; Janine Hale; Cerilan Rogers; Helen Lewis
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.